Integrated Care News by CFHA
MAY 19, 2025
MBC is a clinical process that includes repeated measurement to monitor treatment progress and to inform collaborative treatment planning over the course of care. (1) Read more about CFHA’s call for its widespread adoption across systems, settings, and stakeholders. What is MBC? 1, 8, 9) d. 12-19) What is CFHA’s position on MBC?
FDA Law Blog
DECEMBER 4, 2023
On October 10th, based on ability to pay, the U.S. District Court for the Western District of Texas imposed a $275,000 civil penalty on Zarzamora Healthcare LLC, in San Antonio, and its pharmacist-owner. Federal Court Orders San Antonio-Area Pharmacy and Pharmacist to Pay $275,000 Civil Penalty in Case Alleging Unlawful Opioid Distribution, Oct.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
MARCH 4, 2024
Since the enactment of the Food and Drug Administration Safety and Innovation Act (FDASIA) in 2012, manufacturers have been required to notify FDA of product changes affecting certain finished drugs and biological products. API and its source and any alternative sources; associated medical devices), and expected duration of the interruption.
Pamela Wible MD
JUNE 20, 2025
Since 2012, I’ve spoken to thousands of suicidal doctors—even published a book of physician suicide letters. It’s a growing crisis affecting over half of all doctors in the U.S., and it has been linked to rising rates of physician depression , doctor suicide , and medical errors. It is unclear to me who first applied the term to doctors.
The Clinical Problem Solvers
NOVEMBER 16, 2020
Acknowledging this truth highlights the necessity of mitigating the harms of racism as part of any comprehensive treatment plan. [link] This is the first episode of a three-part series on understanding and dismantling race-based medicine by unearthing its origin and exposing the paucity of rigorous evidence in support of it.
Expert insights. Personalized for you.
100 
Let's personalize your content